Lamivudine therapy in renal allograft recipients with hepatitis B virus infection

Author： Tsang W.K.   Tong K.L.   Chan H.W.H.  

Publisher： Elsevier

ISSN： 0041-1345

Source： Transplantation Proceedings, Vol.35, Iss.1, 2003-02, pp. : 278-279

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of chronic hepatitis B with lamivudine in renal allograft recipients

By Lewandowska D.   Durlik M.   Kukula K.   Cieciura T.   Ciecierski R.   Walewska-Zielecka B.   Szmidt J.   Rowinski W.   Lao M.  

Transplantation Proceedings, Vol. 32, Iss. 6, 2000-09 ,pp. : 1369-1370

Elsevier

Access to resources Recommend Favorite

Efficacy and safety of lamivudine for treatment of chronic hepatitis B in renal allograft recipients

By Alavian S.M.   Hajarizadeh B.   Einollahi B.  

Transplantation Proceedings, Vol. 35, Iss. 7, 2003-11 ,pp. : 2687-2688

Elsevier

Access to resources Recommend Favorite

Impact of hepatitis C virus infection in renal allograft recipients

By Yacheng Y.   Zhilian M.   Yeuhua Z.  

Transplantation Proceedings, Vol. 32, Iss. 7, 2000-11 ,pp. : 1949-1949

Elsevier

Access to resources Recommend Favorite

Lamivudine therapy for severe acute hepatitis B virus infection after renal transplantation: case report and literature review

By Nakhoul F.   Gelman R.   Green J.   Khankin E.   Baruch Y.  

Transplantation Proceedings, Vol. 33, Iss. 6, 2001-09 ,pp. : 2948-2949

Elsevier

Access to resources Recommend Favorite

BK virus infection in renal allograft recipients

By Kang Y.N.   Han S.M.   Park K.K.   Jeon D.S.   Kim H.C.  

Transplantation Proceedings, Vol. 35, Iss. 1, 2003-02 ,pp. : 275-277

Elsevier

Access to resources Recommend Favorite